Grifols (GRFS) Cash & Equivalents (QoQ) (2011 - 2020)

Grifols (GRFS) Cash & Equivalents (QoQ) (2011 - 2020) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	-42.73%
Mar 31, 2020	-14.28%
Dec 31, 2019	-6.82%
Mar 31, 2019	-44.45%
Dec 31, 2018	74.31%
Sep 30, 2018	-15.15%
Jun 30, 2018	-23.29%
Mar 31, 2018	-0.37%
Dec 31, 2016	-3.85%
Sep 30, 2016	10.23%
Jun 30, 2016	-17.96%
Mar 31, 2016	-11.25%
Dec 31, 2015	26.24%
Sep 30, 2015	-99.89%
Jun 30, 2015	96,606.10%
Mar 31, 2015	-33.17%
Dec 31, 2014	10.73%
Sep 30, 2014	20.49%
Jun 30, 2014	7.76%
Mar 31, 2014	-2.75%